Liver X receptor
Liver X Receptor[edit | edit source]
The Liver X Receptor (LXR) is a type of nuclear receptor that functions as a transcription factor regulating the expression of genes involved in cholesterol, fatty acid, and glucose metabolism. LXRs are activated by oxysterols, which are oxidized derivatives of cholesterol.
Types[edit | edit source]
There are two isoforms of the Liver X Receptor:
- LXRα (NR1H3) - Predominantly expressed in the liver, adipose tissue, intestine, and macrophages.
- LXRβ (NR1H2) - Ubiquitously expressed in various tissues throughout the body.
Function[edit | edit source]
LXRs play a crucial role in maintaining cholesterol homeostasis by regulating the expression of genes involved in cholesterol efflux, transport, and excretion. They also influence lipogenesis and gluconeogenesis.
Cholesterol Metabolism[edit | edit source]
LXRs promote the expression of genes such as ABCA1 and ABCG1, which are involved in the efflux of cholesterol from cells to high-density lipoprotein (HDL) particles. This process is essential for the reverse transport of cholesterol from peripheral tissues to the liver for excretion.
Lipid Metabolism[edit | edit source]
In addition to cholesterol metabolism, LXRs regulate genes involved in the synthesis and storage of fatty acids. They activate SREBP-1c, a key transcription factor that promotes the expression of enzymes required for fatty acid synthesis.
Glucose Metabolism[edit | edit source]
LXRs also have a role in glucose metabolism by modulating the expression of genes involved in gluconeogenesis and insulin sensitivity.
Mechanism of Action[edit | edit source]
LXRs function as heterodimers with the retinoid X receptor (RXR). Upon binding to their ligands, LXRs undergo a conformational change that allows them to bind to specific DNA sequences known as LXR response elements (LXREs) in the promoter regions of target genes.
Clinical Significance[edit | edit source]
Due to their role in lipid and glucose metabolism, LXRs are considered potential therapeutic targets for the treatment of atherosclerosis, diabetes, and metabolic syndrome. Agonists of LXRs have been shown to reduce atherosclerotic plaque formation in animal models.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
